サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1121274

世界の髄膜炎菌ワクチン市場：考察と予測 (2028年まで)

Global Meningococcal Vaccine Market Insights and Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 119 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の髄膜炎菌ワクチン市場：考察と予測 (2028年まで)
出版日: 2022年09月02日
発行: QYResearch
ページ情報: 英文 119 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、髄膜炎菌ワクチン (Meningococcal Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 髄膜炎菌ワクチンの製品概要
  • 市場：タイプ別
    • 世界の髄膜炎菌ワクチンの市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Meningtits A
    • Polysaccharide Meningtitis AC
    • Meningitis ACYW
  • 市場：アプリケーション別
    • 世界の髄膜炎菌ワクチンの市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • 6 Months-15Year
    • over 3 Year
    • over 2 Year
    • over 3 Months
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の髄膜炎菌ワクチンの販売 推定および予測 2017-2028
  • 世界の髄膜炎菌ワクチンの収益 推定および予測 2017-2028
  • 世界の髄膜炎菌ワクチンの収益：地域別: 2017 VS 2021 VS 2028
  • 世界の髄膜炎菌ワクチンの販売：地域別
    • 世界の髄膜炎菌ワクチンの販売：地域別 (2017-2022)
    • 世界の販売 髄膜炎菌ワクチン ：地域別 (2023-2028)
  • 世界の髄膜炎菌ワクチンの収益：地域別
    • 世界の髄膜炎菌ワクチンの収益：地域別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界の髄膜炎菌ワクチンの販売：メーカー別
    • 世界の髄膜炎菌ワクチンの上位メーカー：販売別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： 髄膜炎菌ワクチン2021
  • 世界の髄膜炎菌ワクチンの収益：メーカー別
    • 世界の髄膜炎菌ワクチンの収益：メーカー別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： 髄膜炎菌ワクチンの収益 2021
  • 世界の髄膜炎菌ワクチンの販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の髄膜炎菌ワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の髄膜炎菌ワクチンのメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の髄膜炎菌ワクチンの販売：タイプ別
    • 世界の髄膜炎菌ワクチンの販売実績：タイプ別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの販売予測：タイプ別 (2023-2028)
    • 世界の髄膜炎菌ワクチンの販売市場シェア：タイプ別 (2017-2028)
  • 世界の髄膜炎菌ワクチンの収益：タイプ別
    • 世界の髄膜炎菌ワクチンの収益実績：タイプ別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの収益予測：タイプ別 (2023-2028)
    • 世界の髄膜炎菌ワクチンの収益市場シェア：タイプ別 (2017-2028)
  • 世界の髄膜炎菌ワクチンの価格：タイプ別
    • 世界の髄膜炎菌ワクチンの価格：タイプ別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界の髄膜炎菌ワクチンの販売：アプリケーション別
    • 世界の髄膜炎菌ワクチンの販売実績：アプリケーション別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの販売予測：アプリケーション別 (2023-2028)
    • 世界の髄膜炎菌ワクチンの販売市場シェア：アプリケーション別 (2017-2028)
  • 世界の髄膜炎菌ワクチンの収益：アプリケーション別
    • 世界の髄膜炎菌ワクチンの収益実績：アプリケーション別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの収益予測：アプリケーション別 (2023-2028)
    • 世界の髄膜炎菌ワクチンの収益市場シェア：アプリケーション別 (2017-2028)
  • 世界の髄膜炎菌ワクチンの価格：アプリケーション別
    • 世界の髄膜炎菌ワクチンの価格：アプリケーション別 (2017-2022)
    • 世界の髄膜炎菌ワクチンの価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の髄膜炎菌ワクチン 市場規模：タイプ別
    • 北米の髄膜炎菌ワクチンの販売：タイプ別 (2017-2028)
    • 北米の髄膜炎菌ワクチンの収益：タイプ別 (2017-2028)
  • 北米の髄膜炎菌ワクチン 市場規模：アプリケーション別
    • 北米の髄膜炎菌ワクチンの販売：アプリケーション別 (2017-2028)
    • 北米の髄膜炎菌ワクチンの収益：アプリケーション別 (2017-2028)
  • 北米の髄膜炎菌ワクチン 市場規模：国別
    • 北米の髄膜炎菌ワクチンの販売：国別 (2017-2028)
    • 北米の髄膜炎菌ワクチンの収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の髄膜炎菌ワクチン 市場規模：タイプ別
    • 欧州の髄膜炎菌ワクチンの販売：タイプ別 (2017-2028)
    • 欧州の髄膜炎菌ワクチンの収益：タイプ別 (2017-2028)
  • 欧州の髄膜炎菌ワクチン 市場規模：アプリケーション別
    • 欧州の髄膜炎菌ワクチンの販売：アプリケーション別 (2017-2028)
    • 欧州の髄膜炎菌ワクチンの収益：アプリケーション別 (2017-2028)
  • 欧州の髄膜炎菌ワクチン 市場規模：国別
    • 欧州の髄膜炎菌ワクチンの販売：国別 (2017-2028)
    • 欧州の髄膜炎菌ワクチンの収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の髄膜炎菌ワクチン 市場規模：タイプ別
    • アジア太平洋の髄膜炎菌ワクチンの販売：タイプ別 (2017-2028)
    • アジア太平洋の髄膜炎菌ワクチンの収益：タイプ別 (2017-2028)
  • アジア太平洋の髄膜炎菌ワクチン 市場規模：アプリケーション別
    • アジア太平洋の髄膜炎菌ワクチンの販売：アプリケーション別 (2017-2028)
    • アジア太平洋の髄膜炎菌ワクチンの収益：アプリケーション別 (2017-2028)
  • アジア太平洋の髄膜炎菌ワクチン 市場規模：地域別
    • アジア太平洋の髄膜炎菌ワクチンの販売：地域別 (2017-2028)
    • アジア太平洋の髄膜炎菌ワクチンの収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカの髄膜炎菌ワクチン 市場規模：タイプ別
    • ラテンアメリカの髄膜炎菌ワクチンの販売：タイプ別 (2017-2028)
    • ラテンアメリカの髄膜炎菌ワクチンの収益：タイプ別 (2017-2028)
  • ラテンアメリカの髄膜炎菌ワクチン 市場規模：アプリケーション別
    • ラテンアメリカの髄膜炎菌ワクチンの販売：アプリケーション別 (2017-2028)
    • ラテンアメリカの髄膜炎菌ワクチンの収益：アプリケーション別 (2017-2028)
  • ラテンアメリカの髄膜炎菌ワクチン 市場規模：国別
    • ラテンアメリカの髄膜炎菌ワクチンの販売：国別 (2017-2028)
    • ラテンアメリカの髄膜炎菌ワクチンの収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカの髄膜炎菌ワクチン 市場規模：タイプ別
    • 中東・アフリカの髄膜炎菌ワクチンの販売：タイプ別 (2017-2028)
    • 中東・アフリカの髄膜炎菌ワクチンの収益：タイプ別 (2017-2028)
  • 中東・アフリカの髄膜炎菌ワクチン 市場規模：アプリケーション別
    • 中東・アフリカの髄膜炎菌ワクチンの販売：アプリケーション別 (2017-2028)
    • 中東・アフリカの髄膜炎菌ワクチンの収益：アプリケーション別 (2017-2028)
  • 中東・アフリカの髄膜炎菌ワクチン 市場規模：国別
    • 中東・アフリカの髄膜炎菌ワクチンの販売：国別 (2017-2028)
    • 中東・アフリカの髄膜炎菌ワクチンの収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Novartis
  • GSK
  • Merck
  • CSL
  • Baxter
  • JN International Medical Corporation
  • Serum Institute of India
  • Bio-Med
  • China National Biotec Group
  • Hualan Bio
  • Walvax
  • Zhifei

第12章 業界チェーンと販売チャネルの分析

  • 髄膜炎菌ワクチン 業界チェーン分析
  • 髄膜炎菌ワクチン 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 髄膜炎菌ワクチン 生産形態とプロセス
  • 髄膜炎菌ワクチン 販売およびマーケティング
    • 髄膜炎菌ワクチン 販売チャネル
    • 髄膜炎菌ワクチン 卸業者
  • 髄膜炎菌ワクチン 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 髄膜炎菌ワクチン 業界動向
  • 髄膜炎菌ワクチン 市場の促進要因
  • 髄膜炎菌ワクチン 市場の課題
  • 髄膜炎菌ワクチン 市場の抑制要因

第14章 世界の髄膜炎菌ワクチンの主な市場調査結果

第15章 付録

図表
  • Table 1. Global Meningococcal Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Meningtits A
  • Table 3. Major Manufacturers of Polysaccharide Meningtitis AC
  • Table 4. Major Manufacturers of Meningitis ACYW
  • Table 5. Global Meningococcal Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Meningococcal Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Meningococcal Vaccine Sales by Region (2017-2022) & (10K Pcs)
  • Table 8. Global Meningococcal Vaccine Sales Market Share by Region (2017-2022)
  • Table 9. Global Meningococcal Vaccine Sales by Region (2023-2028) & (10K Pcs)
  • Table 10. Global Meningococcal Vaccine Sales Market Share by Region (2023-2028)
  • Table 11. Global Meningococcal Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Meningococcal Vaccine Revenue Market Share by Region (2017-2022)
  • Table 13. Global Meningococcal Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global Meningococcal Vaccine Revenue Market Share by Region (2023-2028)
  • Table 15. Global Meningococcal Vaccine Sales by Manufacturers (2017-2022) & (10K Pcs)
  • Table 16. Global Meningococcal Vaccine Sales Share by Manufacturers (2017-2022)
  • Table 17. Global Meningococcal Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global Meningococcal Vaccine Revenue Share by Manufacturers (2017-2022)
  • Table 19. Meningococcal Vaccine Price by Manufacturers (2017-2022) &(USD/Pcs)
  • Table 20. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2021)
  • Table 22. Meningococcal Vaccine Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Meningococcal Vaccine Product Offered
  • Table 24. Date of Manufacturers Enter into Meningococcal Vaccine Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
  • Table 27. Global Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
  • Table 28. Global Meningococcal Vaccine Sales Share by Type (2017-2022)
  • Table 29. Global Meningococcal Vaccine Sales Share by Type (2023-2028)
  • Table 30. Global Meningococcal Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global Meningococcal Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global Meningococcal Vaccine Revenue Share by Type (2017-2022)
  • Table 33. Global Meningococcal Vaccine Revenue Share by Type (2023-2028)
  • Table 34. Meningococcal Vaccine Price by Type (2017-2022) & (USD/Pcs)
  • Table 35. Global Meningococcal Vaccine Price Forecast by Type (2023-2028) & (USD/Pcs)
  • Table 36. Global Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
  • Table 37. Global Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
  • Table 38. Global Meningococcal Vaccine Sales Share by Application (2017-2022)
  • Table 39. Global Meningococcal Vaccine Sales Share by Application (2023-2028)
  • Table 40. Global Meningococcal Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global Meningococcal Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global Meningococcal Vaccine Revenue Share by Application (2017-2022)
  • Table 43. Global Meningococcal Vaccine Revenue Share by Application (2023-2028)
  • Table 44. Meningococcal Vaccine Price by Application (2017-2022) & (USD/Pcs)
  • Table 45. Global Meningococcal Vaccine Price Forecast by Application (2023-2028) & (USD/Pcs)
  • Table 46. North America Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
  • Table 47. North America Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
  • Table 48. North America Meningococcal Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America Meningococcal Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
  • Table 51. North America Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
  • Table 52. North America Meningococcal Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America Meningococcal Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
  • Table 55. North America Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
  • Table 56. North America Meningococcal Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America Meningococcal Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
  • Table 59. Europe Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
  • Table 60. Europe Meningococcal Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe Meningococcal Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
  • Table 63. Europe Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
  • Table 64. Europe Meningococcal Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe Meningococcal Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
  • Table 67. Europe Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
  • Table 68. Europe Meningococcal Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe Meningococcal Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
  • Table 71. Asia Pacific Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
  • Table 72. Asia Pacific Meningococcal Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific Meningococcal Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
  • Table 75. Asia Pacific Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
  • Table 76. Asia Pacific Meningococcal Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Meningococcal Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Meningococcal Vaccine Sales by Region (2017-2022) & (10K Pcs)
  • Table 79. Asia Pacific Meningococcal Vaccine Sales by Region (2023-2028) & (10K Pcs)
  • Table 80. Asia Pacific Meningococcal Vaccine Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Meningococcal Vaccine Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
  • Table 83. Latin America Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
  • Table 84. Latin America Meningococcal Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America Meningococcal Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
  • Table 87. Latin America Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
  • Table 88. Latin America Meningococcal Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America Meningococcal Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
  • Table 91. Latin America Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
  • Table 92. Latin America Meningococcal Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Meningococcal Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa Meningococcal Vaccine Sales by Type (2017-2022) & (10K Pcs)
  • Table 95. Middle East and Africa Meningococcal Vaccine Sales by Type (2023-2028) & (10K Pcs)
  • Table 96. Middle East and Africa Meningococcal Vaccine Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa Meningococcal Vaccine Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Meningococcal Vaccine Sales by Application (2017-2022) & (10K Pcs)
  • Table 99. Middle East and Africa Meningococcal Vaccine Sales by Application (2023-2028) & (10K Pcs)
  • Table 100. Middle East and Africa Meningococcal Vaccine Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Meningococcal Vaccine Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Meningococcal Vaccine Sales by Country (2017-2022) & (10K Pcs)
  • Table 103. Middle East and Africa Meningococcal Vaccine Sales by Country (2023-2028) & (10K Pcs)
  • Table 104. Middle East and Africa Meningococcal Vaccine Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Meningococcal Vaccine Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. Novartis Corporation Information
  • Table 107. Novartis Description and Major Businesses
  • Table 108. Novartis Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 109. Novartis Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. Novartis Recent Developments
  • Table 111. GSK Corporation Information
  • Table 112. GSK Description and Major Businesses
  • Table 113. GSK Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 114. GSK Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. GSK Recent Developments
  • Table 116. Merck Corporation Information
  • Table 117. Merck Description and Major Businesses
  • Table 118. Merck Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 119. Merck Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Merck Recent Developments
  • Table 121. CSL Corporation Information
  • Table 122. CSL Description and Major Businesses
  • Table 123. CSL Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 124. CSL Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. CSL Recent Developments
  • Table 126. Baxter Corporation Information
  • Table 127. Baxter Description and Major Businesses
  • Table 128. Baxter Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 129. Baxter Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Baxter Recent Developments
  • Table 131. JN International Medical Corporation Corporation Information
  • Table 132. JN International Medical Corporation Description and Major Businesses
  • Table 133. JN International Medical Corporation Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 134. JN International Medical Corporation Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. JN International Medical Corporation Recent Developments
  • Table 136. Serum Institute of India Corporation Information
  • Table 137. Serum Institute of India Description and Major Businesses
  • Table 138. Serum Institute of India Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 139. Serum Institute of India Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Serum Institute of India Recent Developments
  • Table 141. Bio-Med Corporation Information
  • Table 142. Bio-Med Description and Major Businesses
  • Table 143. Bio-Med Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 144. Bio-Med Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. Bio-Med Recent Developments
  • Table 146. China National Biotec Group Corporation Information
  • Table 147. China National Biotec Group Description and Major Businesses
  • Table 148. China National Biotec Group Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 149. China National Biotec Group Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. China National Biotec Group Recent Developments
  • Table 151. Hualan Bio Corporation Information
  • Table 152. Hualan Bio Description and Major Businesses
  • Table 153. Hualan Bio Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 154. Hualan Bio Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. Hualan Bio Recent Developments
  • Table 156. Walvax Corporation Information
  • Table 157. Walvax Description and Major Businesses
  • Table 158. Walvax Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 159. Walvax Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 160. Walvax Recent Developments
  • Table 161. Zhifei Corporation Information
  • Table 162. Zhifei Description and Major Businesses
  • Table 163. Zhifei Meningococcal Vaccine Sales (10K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 164. Zhifei Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 165. Zhifei Recent Developments
  • Table 166. Key Raw Materials Lists
  • Table 167. Raw Materials Key Suppliers Lists
  • Table 168. Meningococcal Vaccine Distributors List
  • Table 169. Meningococcal Vaccine Customers List
  • Table 170. Meningococcal Vaccine Market Trends
  • Table 171. Meningococcal Vaccine Market Drivers
  • Table 172. Meningococcal Vaccine Market Challenges
  • Table 173. Meningococcal Vaccine Market Restraints
  • Table 174. Research Programs/Design for This Report
  • Table 175. Key Data Information from Secondary Sources
  • Table 176. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Meningococcal Vaccine Product Picture
  • Figure 3. Global Meningococcal Vaccine Market Share by Type in 2021 & 2028
  • Figure 3. Meningtits A Product Picture
  • Figure 4. Polysaccharide Meningtitis AC Product Picture
  • Figure 5. Meningitis ACYW Product Picture
  • Figure 6. Global Meningococcal Vaccine Market Share by Application in 2021 & 2028
  • Figure 7. 6 Months-15Year
  • Figure 8. over 3 Year
  • Figure 9. over 2 Year
  • Figure 10. over 3 Months
  • Figure 11. Meningococcal Vaccine Report Years Considered
  • Figure 12. Global Meningococcal Vaccine Sales 2017-2028 (10K Pcs)
  • Figure 13. Global Meningococcal Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Meningococcal Vaccine Revenue 2017-2028 (US$ Million)
  • Figure 15. Global Meningococcal Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 16. Global Meningococcal Vaccine Sales Market Share by Region (2017-2022)
  • Figure 17. Global Meningococcal Vaccine Sales Market Share by Region (2023-2028)
  • Figure 18. North America Meningococcal Vaccine Sales YoY (2017-2028) & (10K Pcs)
  • Figure 19. North America Meningococcal Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Europe Meningococcal Vaccine Sales YoY (2017-2028) & (10K Pcs)
  • Figure 21. Europe Meningococcal Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Asia-Pacific Meningococcal Vaccine Sales YoY (2017-2028) & (10K Pcs)
  • Figure 23. Asia-Pacific Meningococcal Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Latin America Meningococcal Vaccine Sales YoY (2017-2028) & (10K Pcs)
  • Figure 25. Latin America Meningococcal Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. Middle East & Africa Meningococcal Vaccine Sales YoY (2017-2028) & (10K Pcs)
  • Figure 27. Middle East & Africa Meningococcal Vaccine Revenue YoY (2017-2028) & (US$ Million)
  • Figure 28. The Meningococcal Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Meningococcal Vaccine in the World: Market Share by Meningococcal Vaccine Revenue in 2021
  • Figure 30. Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 31. Global Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • Figure 32. Global Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 33. Global Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • Figure 34. Global Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 35. North America Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • Figure 36. North America Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 37. North America Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • Figure 38. North America Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 39. North America Meningococcal Vaccine Sales Share by Country (2017-2028)
  • Figure 40. North America Meningococcal Vaccine Revenue Share by Country (2017-2028)
  • Figure 41. U.S. Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 42. Canada Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 43. Europe Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • Figure 44. Europe Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 45. Europe Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • Figure 46. Europe Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 47. Europe Meningococcal Vaccine Sales Share by Country (2017-2028)
  • Figure 48. Europe Meningococcal Vaccine Revenue Share by Country (2017-2028)
  • Figure 49. Germany Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 50. France Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 51. U.K. Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 52. Italy Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 53. Russia Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 54. Asia Pacific Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • Figure 55. Asia Pacific Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 56. Asia Pacific Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • Figure 57. Asia Pacific Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 58. Asia Pacific Meningococcal Vaccine Sales Share by Region (2017-2028)
  • Figure 59. Asia Pacific Meningococcal Vaccine Revenue Share by Region (2017-2028)
  • Figure 60. China Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 61. Japan Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 62. South Korea Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 63. India Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 64. Australia Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 65. China Taiwan Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 66. Indonesia Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 67. Thailand Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 68. Malaysia Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 69. Latin America Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • Figure 70. Latin America Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 71. Latin America Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • Figure 72. Latin America Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 73. Latin America Meningococcal Vaccine Sales Share by Country (2017-2028)
  • Figure 74. Latin America Meningococcal Vaccine Revenue Share by Country (2017-2028)
  • Figure 75. Mexico Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 76. Brazil Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 77. Argentina Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 78. Middle East and Africa Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • Figure 80. Middle East and Africa Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • Figure 82. Middle East and Africa Meningococcal Vaccine Sales Share by Country (2017-2028)
  • Figure 83. Middle East and Africa Meningococcal Vaccine Revenue Share by Country (2017-2028)
  • Figure 84. Turkey Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 85. Saudi Arabia Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 86. UAE Meningococcal Vaccine Revenue (2017-2028) & (US$ Million)
  • Figure 87. Meningococcal Vaccine Value Chain
  • Figure 88. Meningococcal Vaccine Production Process
  • Figure 89. Channels of Distribution
  • Figure 90. Distributors Profiles
  • Figure 91. Bottom-up and Top-down Approaches for This Report
  • Figure 92. Data Triangulation
  • Figure 93. Key Executives Interviewed
目次

This research report focuses on the Meningococcal Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Meningococcal Vaccine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Meningococcal Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Meningtits A
    • 1.2.3 Polysaccharide Meningtitis AC
    • 1.2.4 Meningitis ACYW
  • 1.3 Market by Application
    • 1.3.1 Global Meningococcal Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 6 Months-15Year
    • 1.3.3 over 3 Year
    • 1.3.4 over 2 Year
    • 1.3.5 over 3 Months
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Meningococcal Vaccine Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Meningococcal Vaccine Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Meningococcal Vaccine Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Meningococcal Vaccine Sales by Region
    • 2.4.1 Global Meningococcal Vaccine Sales by Region (2017-2022)
    • 2.4.2 Global Sales Meningococcal Vaccine by Region (2023-2028)
  • 2.5 Global Meningococcal Vaccine Revenue by Region
    • 2.5.1 Global Meningococcal Vaccine Revenue by Region (2017-2022)
    • 2.5.2 Global Meningococcal Vaccine Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Meningococcal Vaccine Sales by Manufacturers
    • 3.1.1 Global Top Meningococcal Vaccine Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Meningococcal Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Meningococcal Vaccine in 2021
  • 3.2 Global Meningococcal Vaccine Revenue by Manufacturers
    • 3.2.1 Global Meningococcal Vaccine Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Meningococcal Vaccine Revenue in 2021
  • 3.3 Global Meningococcal Vaccine Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Meningococcal Vaccine Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Meningococcal Vaccine Sales by Type
    • 4.1.1 Global Meningococcal Vaccine Historical Sales by Type (2017-2022)
    • 4.1.2 Global Meningococcal Vaccine Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Meningococcal Vaccine Sales Market Share by Type (2017-2028)
  • 4.2 Global Meningococcal Vaccine Revenue by Type
    • 4.2.1 Global Meningococcal Vaccine Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Meningococcal Vaccine Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Meningococcal Vaccine Revenue Market Share by Type (2017-2028)
  • 4.3 Global Meningococcal Vaccine Price by Type
    • 4.3.1 Global Meningococcal Vaccine Price by Type (2017-2022)
    • 4.3.2 Global Meningococcal Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Meningococcal Vaccine Sales by Application
    • 5.1.1 Global Meningococcal Vaccine Historical Sales by Application (2017-2022)
    • 5.1.2 Global Meningococcal Vaccine Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Meningococcal Vaccine Sales Market Share by Application (2017-2028)
  • 5.2 Global Meningococcal Vaccine Revenue by Application
    • 5.2.1 Global Meningococcal Vaccine Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Meningococcal Vaccine Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Meningococcal Vaccine Revenue Market Share by Application (2017-2028)
  • 5.3 Global Meningococcal Vaccine Price by Application
    • 5.3.1 Global Meningococcal Vaccine Price by Application (2017-2022)
    • 5.3.2 Global Meningococcal Vaccine Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Meningococcal Vaccine Market Size by Type
    • 6.1.1 North America Meningococcal Vaccine Sales by Type (2017-2028)
    • 6.1.2 North America Meningococcal Vaccine Revenue by Type (2017-2028)
  • 6.2 North America Meningococcal Vaccine Market Size by Application
    • 6.2.1 North America Meningococcal Vaccine Sales by Application (2017-2028)
    • 6.2.2 North America Meningococcal Vaccine Revenue by Application (2017-2028)
  • 6.3 North America Meningococcal Vaccine Market Size by Country
    • 6.3.1 North America Meningococcal Vaccine Sales by Country (2017-2028)
    • 6.3.2 North America Meningococcal Vaccine Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Meningococcal Vaccine Market Size by Type
    • 7.1.1 Europe Meningococcal Vaccine Sales by Type (2017-2028)
    • 7.1.2 Europe Meningococcal Vaccine Revenue by Type (2017-2028)
  • 7.2 Europe Meningococcal Vaccine Market Size by Application
    • 7.2.1 Europe Meningococcal Vaccine Sales by Application (2017-2028)
    • 7.2.2 Europe Meningococcal Vaccine Revenue by Application (2017-2028)
  • 7.3 Europe Meningococcal Vaccine Market Size by Country
    • 7.3.1 Europe Meningococcal Vaccine Sales by Country (2017-2028)
    • 7.3.2 Europe Meningococcal Vaccine Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Meningococcal Vaccine Market Size by Type
    • 8.1.1 Asia Pacific Meningococcal Vaccine Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Meningococcal Vaccine Market Size by Application
    • 8.2.1 Asia Pacific Meningococcal Vaccine Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Meningococcal Vaccine Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Meningococcal Vaccine Market Size by Region
    • 8.3.1 Asia Pacific Meningococcal Vaccine Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Meningococcal Vaccine Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Meningococcal Vaccine Market Size by Type
    • 9.1.1 Latin America Meningococcal Vaccine Sales by Type (2017-2028)
    • 9.1.2 Latin America Meningococcal Vaccine Revenue by Type (2017-2028)
  • 9.2 Latin America Meningococcal Vaccine Market Size by Application
    • 9.2.1 Latin America Meningococcal Vaccine Sales by Application (2017-2028)
    • 9.2.2 Latin America Meningococcal Vaccine Revenue by Application (2017-2028)
  • 9.3 Latin America Meningococcal Vaccine Market Size by Country
    • 9.3.1 Latin America Meningococcal Vaccine Sales by Country (2017-2028)
    • 9.3.2 Latin America Meningococcal Vaccine Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Meningococcal Vaccine Market Size by Type
    • 10.1.1 Middle East and Africa Meningococcal Vaccine Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Meningococcal Vaccine Market Size by Application
    • 10.2.1 Middle East and Africa Meningococcal Vaccine Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Meningococcal Vaccine Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Meningococcal Vaccine Market Size by Country
    • 10.3.1 Middle East and Africa Meningococcal Vaccine Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Meningococcal Vaccine Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Overview
    • 11.1.3 Novartis Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Novartis Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Novartis Recent Developments
  • 11.2 GSK
    • 11.2.1 GSK Corporation Information
    • 11.2.2 GSK Overview
    • 11.2.3 GSK Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 GSK Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 GSK Recent Developments
  • 11.3 Merck
    • 11.3.1 Merck Corporation Information
    • 11.3.2 Merck Overview
    • 11.3.3 Merck Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Merck Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Merck Recent Developments
  • 11.4 CSL
    • 11.4.1 CSL Corporation Information
    • 11.4.2 CSL Overview
    • 11.4.3 CSL Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 CSL Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 CSL Recent Developments
  • 11.5 Baxter
    • 11.5.1 Baxter Corporation Information
    • 11.5.2 Baxter Overview
    • 11.5.3 Baxter Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Baxter Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Baxter Recent Developments
  • 11.6 JN International Medical Corporation
    • 11.6.1 JN International Medical Corporation Corporation Information
    • 11.6.2 JN International Medical Corporation Overview
    • 11.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 JN International Medical Corporation Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 JN International Medical Corporation Recent Developments
  • 11.7 Serum Institute of India
    • 11.7.1 Serum Institute of India Corporation Information
    • 11.7.2 Serum Institute of India Overview
    • 11.7.3 Serum Institute of India Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Serum Institute of India Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Serum Institute of India Recent Developments
  • 11.8 Bio-Med
    • 11.8.1 Bio-Med Corporation Information
    • 11.8.2 Bio-Med Overview
    • 11.8.3 Bio-Med Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Bio-Med Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Bio-Med Recent Developments
  • 11.9 China National Biotec Group
    • 11.9.1 China National Biotec Group Corporation Information
    • 11.9.2 China National Biotec Group Overview
    • 11.9.3 China National Biotec Group Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 China National Biotec Group Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 China National Biotec Group Recent Developments
  • 11.10 Hualan Bio
    • 11.10.1 Hualan Bio Corporation Information
    • 11.10.2 Hualan Bio Overview
    • 11.10.3 Hualan Bio Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Hualan Bio Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Hualan Bio Recent Developments
  • 11.11 Walvax
    • 11.11.1 Walvax Corporation Information
    • 11.11.2 Walvax Overview
    • 11.11.3 Walvax Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 Walvax Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Walvax Recent Developments
  • 11.12 Zhifei
    • 11.12.1 Zhifei Corporation Information
    • 11.12.2 Zhifei Overview
    • 11.12.3 Zhifei Meningococcal Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Zhifei Meningococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Zhifei Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Meningococcal Vaccine Industry Chain Analysis
  • 12.2 Meningococcal Vaccine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Meningococcal Vaccine Production Mode & Process
  • 12.4 Meningococcal Vaccine Sales and Marketing
    • 12.4.1 Meningococcal Vaccine Sales Channels
    • 12.4.2 Meningococcal Vaccine Distributors
  • 12.5 Meningococcal Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Meningococcal Vaccine Industry Trends
  • 13.2 Meningococcal Vaccine Market Drivers
  • 13.3 Meningococcal Vaccine Market Challenges
  • 13.4 Meningococcal Vaccine Market Restraints

14 Key Findings in The Global Meningococcal Vaccine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer